Cargando…

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)

The synthetic psychostimulant MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) acts as an indirect serotonin, dopamine, and norepinephrine agonist and as a mechanism-based inhibitor of the cytochrome P-450 2D6 (CYP2D6). It has been suggested that women are more sensitive to MDMA effects than men b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pardo-Lozano, Ricardo, Farré, Magí, Yubero-Lahoz, Samanta, O’Mathúna, Brian, Torrens, Marta, Mustata, Cristina, Pérez-Mañá, Clara, Langohr, Klaus, Cuyàs, Elisabet, Carbó, Marcel·lí, de la Torre, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480420/ https://www.ncbi.nlm.nih.gov/pubmed/23112822 http://dx.doi.org/10.1371/journal.pone.0047599

Ejemplares similares

Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation
por: Puerta, Elena, et al.
Publicado: (2011)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022)

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
por: Wunderli, Michael D, et al.
Publicado: (2017)

MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?
por: de la Torre, Rafael, et al.
Publicado: (2012)

Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
por: Kamboj, Sunjeev K., et al.
Publicado: (2017)

Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy)
por: Movassaghi, Shabnam, et al.
Publicado: (2013)

The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance
por: Cuyàs, Elisabet, et al.
Publicado: (2011)

3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013)

Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.
por: McCoy, E. P., et al.
Publicado: (1994)

Ecstasy (MDMA): A rebellion coherent with the system
por: García-Montes, José Manuel, et al.
Publicado: (2020)

No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT(1a) Receptor Activation
por: Kuypers, Kim P. C., et al.
Publicado: (2014)

Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

Methylenedioxymethamphetamine (MDMA)-Induced Hyponatremia: Case Report and Literature Review
por: Elkattawy, Sherif, et al.
Publicado: (2021)

Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
por: Oeri, Hans Emanuel
Publicado: (2020)

Ecstasy (MDMA) and its effects on kidneys and their treatment: a review
por: Bora, Feyza, et al.
Publicado: (2016)

Caffeine and MDMA (Ecstasy) Exacerbate ER Stress Triggered by Hyperthermia
por: Trychta, Kathleen A., et al.
Publicado: (2022)

MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology
por: Sáez-Briones, P., et al.
Publicado: (2013)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review
por: Inouye, Ann, et al.
Publicado: (2022)

Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines
por: Gouzoulis-Mayfrank, Euphrosyne, et al.
Publicado: (2009)

Autophagy Activation Is Involved in 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)—Induced Neurotoxicity in Cultured Cortical Neurons
por: Li, I-Hsun, et al.
Publicado: (2014)

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
por: Baumann, Michael H., et al.
Publicado: (2006)

The influence of the host microbiome on 3,4-methylenedioxymethamphetamine (MDMA)-induced hyperthermia and vice versa
por: Ridge, Emily A., et al.
Publicado: (2019)

Extracorporeal Membrane Oxygenation Support in Refractory Multi-organ Failure by 3,4-Methylenedioxymethamphetamine Intoxication (“Ecstasy”)
por: Ruiz, Victoria, et al.
Publicado: (2022)

Pharmacological effects of methylone and MDMA in humans
por: Poyatos, Lourdes, et al.
Publicado: (2023)

Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter
por: Kuypers, K. P. C., et al.
Publicado: (2018)

Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model
por: Jamshidfar, Sanaz, et al.
Publicado: (2017)

The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis
por: Biezonski, Dominik K, et al.
Publicado: (2011)

Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
por: Górska, Anna Maria, et al.
Publicado: (2017)

Effects of Repeated Administration of 3,4-methylenedioxymethamphetamine (MDMA) on Avoidance Memory and Cell Density in Rats’ Hippocampus
por: Jahanshahi, Mehrdad, et al.
Publicado: (2013)

Two Simulation Cases to Prepare for a Public Festival: Pediatric Methylenedioxymethamphetamine (MDMA) Ingestion and Alcohol Toxicity
por: Roben, Emily Z, et al.
Publicado: (2018)

Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations
por: Neumann, Joachim, et al.
Publicado: (2022)

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
por: Poyatos, Lourdes, et al.
Publicado: (2021)

Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis
por: Regan, Annie, et al.
Publicado: (2021)

Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
por: Bavato, F., et al.
Publicado: (2022)

Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data
por: Salvatore, Stefania, et al.
Publicado: (2016)

COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population
por: Aytac, Hasan Mervan, et al.
Publicado: (2022)

Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing
por: Agurto, Carla, et al.
Publicado: (2020)

Differential sensitivity to detect prosocial effects of 3,4‐methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice
por: Mukai, Satoko, et al.
Publicado: (2020)

Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex
por: Zimmermann, Josua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_481crb91ejs7op9s0iskonq16v